The UK has tightened regulation for clinical trials in recent years. Reaction from the industry has been strong, with some suggesting legislation and high costs will kill off research and development (R&D) innovation and clinical research in the UK  
Lab Manager September 2015 Mike May looks into the growing importance of mobile features for electronic lab notebooks – featuring comments from VP Strategic Solutions, Paul Denny-Gouldson, and IDBS technology partner ACD/Labs. Read the article here »About IDBSContact us More…
BioPharma Dive September 2015 BioPharma Dive covers the recent appointment of our CTO, Peter Murray, and the deliberate shift IDBS is making to accelerate innovation and bring new products to the market. Read the article here »About IDBSContact us More…
Pharmaceutical and chemistry-related businesses have bemoaned the negative impact of regulation on innovation and, more recently, a decision to cut $2.4bn from the European Commission’s flagship science research program, Horizon 2020. In contrast, the US aims to increase its National…
The pitfalls of automating the past While moving to electronic systems for scientific data management brings clear benefits, the risks for organizations is that implementation seeks to automate past, paper-based processes. The result is that data goes from being…